Rhoads is a healthcare finance executive with more than 25 years of experience which includes roles as chief financial officer of two companies, raising over $400 million through public and private offerings, and service as a board director and chair of audit and compensation committees across several public and private boards. In addition to her operating roles in healthcare companies, she has experience as an executive with the VC firm Sprout Group, and the management consulting firm Bain & Company.
Sandoval has a track record of successful business leadership and development of leading brands in a variety of areas including the medical aesthetics arena. She currently serves as chief commercial officer for Alder Biopharmaceuticals and previously was chief commercial officer at Kythera Biopharmaceuticals, which was sold to Allergan in 2015. Prior to this appointment, Sandoval spent 24 years at Allergan Inc., where she held the role of vice president, global strategic marketing, and drove the launch of the market-leading Juvederm dermal filler and established its worldwide marketing team.